Sitemap

December 08, 2005 Articles

Filter by Available Specialty
  1. FDA issues warning on Miracle II products
  2. Infection rate with 30-day continuous wear comparable to rates with
  3. Phase 3 trial planned for aprotinin in spinal surgery
  4. Study: Retinal vascular abnormalities associated with ‘silent stroke’